Integrated Drug Discovery

Charles River utilizes a truly integrated approach to small molecule drug discovery, uniting all of the key disciplines required to achieve a program's goals in a single project team. As an experienced drug discovery organization, we are able to tailor project resources to meet the client's specific needs, integrating chemistry, physical sciences, CADD, biology, structural biology, ADMET/PK and disease models as required. The acquisition of Argenta and Biofocus positions us as an early-stage CRO with in vitro and in vivo capabilities from target identification and validation through preclinical development.

• Discover and validate drug targets.

• Identify hit compounds for my target.

• Optimize my lead compounds to candidate status.

• Convert my hits into leads.